Derfor bør Fablyn kun bruges til behandling af osteoporose, efter at behandlingen for mammacancer, herunder adjuverende behandling, er afsluttet.
Therefore, FABLYN should be used for the treatment of osteoporosis only after the treatment of breast cancer, including adjuvant therapy, has been completed.